Astra Industrial Group announces its Interim Financial Results for the Period Ending on 2021-06-30 ( Six Months )

Element List	Current Quarter	Similar quarter for previous year	%Change	Previous Quarter	% Change
Sales/Revenue	536,985,130	441,511,675	21.624	599,285,124	-10.395
Gross Profit (Loss)	199,738,959	165,759,154	20.499	249,390,235	-19.909
Operational Profit (Loss)	63,769,429	43,270,268	47.374	107,426,446	-40.638
Net Profit (Loss) after Zakat and Tax	54,599,836	24,223,085	125.404	50,605,768	7.892
Total Comprehensive Income	48,500,974	24,621,155	96.989	38,024,819	27.55
All figures are in (Actual) Saudi Arabia, Riyals

Element List	Current Period	Similar period for previous year	%Change
Sales/Revenue	1,136,270,254	951,021,347	19.478
Gross Profit (Loss)	449,129,194	372,925,558	20.434
Operational Profit (Loss)	171,195,875	106,317,749	61.022
Net Profit (Loss) after Zakat and Tax	105,205,604	58,316,688	80.403
Total Comprehensive Income	86,525,793	48,261,932	79.283
Total Share Holders Equity (after Deducting Minority Equity)	1,352,372,354	1,257,449,426	7.548
Profit (Loss) per Share	1.32	0.73
All figures are in (Actual) Saudi Arabia, Riyals

Element List	Explanation
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is	Net profit increases in general due to:

1. Increase in sales in all sectors

2. Increase in other income in the following sectors:

a. Pharmaceuticals sector

b. Power and steel sector

c. Specialty chemical sector

While noting that there is increase in Selling and Distribution expenses in the Specialty chemicals sector and General and administration expenses in Pharmaceuticals and Other sectors.The reason of the increase (decrease) in the net profit during the current quarter compared to the previous period of the current year is Net profit increases in general due to:

1. Decrease in other expenses in the following sectors:

a. Pharmaceuticals sector

b. Specialty chemical sector

c. Power and steel sector

2. Decrease in provision for impairment for financial assets expense in the following sectors:

a. Specialty chemical sector

b. Pharmaceuticals sector

3. Decrease in General and administration expenses in Specialty chemical sector and other sector

While noting that there is drop in sales and Gross profit in pharmaceuticals and specialty chemical sectors.The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is Net profit increases in general due to:

1. Increase in sales in all sectors.

2. Decrease in Selling and Distribution expenses in the following sectors:

a) Pharmaceuticals sector

b) Power and steel sector

While noting that there is increase in other expenses in the Pharmaceuticals sector and provision for impairment of financial assets expense for Specialty Chemicals sector.Statement of the type of external auditor's report Unmodified conclusionReclassification of Comparison Items No comparative figures for the previous period have been reclassifiedAdditional Information 1. Net Shareholders’ Equity at the end of the period was SR1,407,057,157/- compared to SR1,254,407,940/- at the end of the similar period last year with an increase of 12%.

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.